MEDICURE INC. Files August 2025 6-K Report
Ticker: MCUJF · Form: 6-K · Filed: Aug 21, 2025 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Aug 21, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
MEDICURE INC. filed its monthly 6-K, just routine compliance stuff.
AI Summary
On August 21, 2025, MEDICURE INC. filed a Form 6-K for the month of August 2025. The company, headquartered at 1250 Waverley Street, Winnipeg, MB Canada R3T 6C6, is a foreign private issuer and files its annual reports under Form 20-F. This filing does not appear to contain specific financial transactions or material updates beyond its routine reporting status.
Why It Matters
This filing indicates that MEDICURE INC. is fulfilling its reporting obligations as a foreign private issuer. Investors can use this to confirm ongoing compliance and access routine disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material information that would typically impact risk.
Key Players & Entities
- MEDICURE INC. (company) — Filer of the 6-K report
- 1250 Waverley Street, Winnipeg, MB Canada R3T 6C6 (location) — Principal executive offices address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer makes public in its home country.
Which form does MEDICURE INC. use for its annual reports?
MEDICURE INC. files its annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of August 21, 2025.
What is the principal business address of MEDICURE INC.?
The principal executive offices are located at 1250 Waverley Street, Winnipeg, MB Canada R3T 6C6.
Is MEDICURE INC. submitting this Form 6-K in paper format as permitted by Regulation S-T?
The filing indicates that MEDICURE INC. is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Filing Stats: 243 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2025-08-20 18:06:44
Filing Documents
- med_6k.htm (6-K) — 9KB
- med_ex991.htm (EX-99.1) — 13KB
- med_ex991img2.jpg (GRAPHIC) — 3KB
- 0001654954-25-009864.txt ( ) — 28KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: August 18, 2025 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3